ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2025

Plasma cell-directed therapies induce profound clinical and durable responses in patients with severe or relapsed/refractory scleromyxedema.

F Theves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.